Loading...

Nova Eye Medical Limited

ELXMFPNK
Healthcare
Medical - Devices
$0.10
$0.00(0.00%)

Nova Eye Medical Limited (ELXMF) Company Profile & Overview

Explore Nova Eye Medical Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Nova Eye Medical Limited (ELXMF) Company Profile & Overview

Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.

SectorHealthcare
IndustryMedical - Devices
CEOVictor Previn

Contact Information

61 8 8362 0193
107 Rundle Street, Kent Town, SA, 5067

Company Facts

IPO DateJan 20, 2010
CountryAU
Actively Trading

Frequently Asked Questions

;